关于加密多焦点性狭窄性肠病变 (CMUSE) 和非类固醇肠病变的诊断和管理的最新信息
Tom G Moreels1, Ayaskanta Singh2
1University Hospital Saint-Luc, Department of Gastroenterology & Hepatology, Ave Hippocrate 10, 1200, Brussels, Belgium.
Best practice & research. Clinical gastroenterology
|August 31, 2023
概括
罕见的性肠道病变,密码性多焦点性性狭窄性肠炎/肠道病变 (CMUSE) 和慢性非特异性小肠多发性 (CNSU),都与前列腺素相关. 区分它们与NSAID诱导的肠病是有效治疗的关键.
科学领域:
- 胃肠病学 胃肠病学
- 小肠疾病 小肠疾病
- 炎症性肠道疾病是什么
背景情况:
- 克罗恩病和乳病是小肠的已知原因.
- 罕见的慢性小肠性疾病,包括CMUSE和CNSU,已经得到了先进的内镜技术的关注.
- 目前,CMUSE和CNSU已被认为是与前列腺素相关的肠病.
研究的目的:
- 提供密码多焦点性性狭窄性肠炎/肠道病变 (CMUSE) 和慢性小肠不特定多重 (CNSU) 的概述.
- 讨论这些罕见的肠道病变的病因和治疗选择.
- 为了区分CMUSE和CNSU与NSAID诱导的肠病.
主要方法:
- 审查关于CMUSE和CNSU的历史出版物.
- 对 enteropathies 的当前诊断方法的分析.
- 讨论治疗策略和差异诊断,特别是关于NSAID诱导的肠病.
主要成果:
- CMUSE和CNSU是前列腺素相关性肠病中不同的实体,与特定的易感基因相关.
- 最初在欧洲报告了CMUSE,而在日本患者中诊断了CNSU.
- 病模式的相似性需要与NSAID诱导的肠病症进行仔细的区分.
结论:
- 密码多焦点性性狭窄性肠炎/肠道病变 (CMUSE) 和慢性小肠非特异性多发性 (CNSU) 是罕见的,独特的前列腺素相关肠道病变.
- 了解它们的独特特征和遗传联系对于准确诊断至关重要.
- 区分这些疾病与NSAID诱导的肠病症对于适当的患者管理和治疗至关重要.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
01:29Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213
01:21Inflammatory Bowel Disease V: Surgical Management
167
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
167
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:26Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110